141 related articles for article (PubMed ID: 22706252)
21. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.
Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Serum Free Light Chain in Multiple Myeloma.
El Naggar AA; El-Naggar M; Mokhamer el-H; Avad MW
Egypt J Immunol; 2015; 22(1):69-78. PubMed ID: 26415374
[TBL] [Abstract][Full Text] [Related]
23. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of unexpected protein bands in multiple myeloma patients after autologous stem cell transplantation.
Kim SK; Jeong TD; Kim SY; Lee W; Chun S; Suh CW; Min WK
Clin Biochem; 2014 May; 47(7-8):588-92. PubMed ID: 24582697
[TBL] [Abstract][Full Text] [Related]
25. Significance of oligoclonal bands after stem cell transplantation in multiple myeloma cases.
Liu AJ; Zong H; Yang GZ; Zhai YH; Li LH
Asian Pac J Cancer Prev; 2012; 13(4):1483-6. PubMed ID: 22799352
[TBL] [Abstract][Full Text] [Related]
26. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
27. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
28. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
29. Serum free light chain response after 2 courses of induction chemotherapy predicts prognosis in myeloma patients.
Yağcı M; Karakaya F; Suyanı E; Haznedar R
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):98-102. PubMed ID: 25441109
[TBL] [Abstract][Full Text] [Related]
30. [The significance of serum IgD quantitation for evaluation of clinical efficacy in IgD multiple myeloma].
He J; Zhang H; Jiang H; Zeng T; Chang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):288-91. PubMed ID: 27093990
[TBL] [Abstract][Full Text] [Related]
31. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.
McTaggart MP; Lindsay J; Kearney EM
Am J Clin Pathol; 2013 Dec; 140(6):890-7. PubMed ID: 24225758
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma.
Jo JC; Yoon DH; Kim S; Lee K; Kang EH; Jang S; Park CJ; Chi HS; Huh J; Park CS; Suh C
Ann Hematol; 2014 Mar; 93(3):463-9. PubMed ID: 23999647
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.
Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population.
Piehler AP; Gulbrandsen N; Kierulf P; Urdal P
Clin Chem; 2008 Nov; 54(11):1823-30. PubMed ID: 18801937
[TBL] [Abstract][Full Text] [Related]
35. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
36. Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.
Rodríguez-Lobato LG; Fernández de Larrea C; Cibeira MT; Tovar N; Aróstegui JI; Rosiñol L; Díaz T; Lozano E; Elena M; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1269-1275. PubMed ID: 28434927
[TBL] [Abstract][Full Text] [Related]
37. Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Özkurt ZN; Sucak GT; Akı ŞZ; Yağcı M; Haznedar R
Cancer Invest; 2017 Mar; 35(3):195-201. PubMed ID: 28112977
[TBL] [Abstract][Full Text] [Related]
38. Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma.
Barley K; Tindle S; Bagiella E; Jagannath S; Chari A
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):541-5. PubMed ID: 26119495
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
Ansari AA; Tipu HN; Ahmed D; Farhan M
Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
[TBL] [Abstract][Full Text] [Related]
40. Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma.
Meddour Y; Rahali MC; Belakehal SE; Ardjoun FZ; Chaib S; Djidjik R
Clin Lab; 2018 Apr; 64(4):551-558. PubMed ID: 29739080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]